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Department of Physiology and Biophysics, Howard Hughes Medical Institute, University of Washington, Seattle, WashingtonABSTRACT Fluorescence spectroscopy is an indispensible tool for studying the structure and conformational dynamics of
protein molecules both in isolation and in their cellular context. The ideal probes for monitoring intramolecular protein motions
are small, cysteine-reactive fluorophores. However, it can be difficult to obtain specific labeling of a desired cysteine in proteins
with multiple cysteines, in a mixture of proteins, or in a protein’s native environment, in which many cysteine-containing proteins
are present. To obtain specific labeling, we developed a method we call cysteine metal protection and labeling (CyMPL). With
this method, a desired cysteine can be reversibly protected by binding group 12 metal ions (e.g., Cd2þ and Zn2þ) while back-
ground cysteines are blocked with nonfluorescent covalent modifiers. We increased the metal affinity for specific cysteines
by incorporating them into minimal binding sites in existing secondary structural motifs (i.e., a-helix or b-strand). After the metal
ions were removed, the deprotected cysteines were then available to specifically react with a fluorophore.INTRODUCTIONFluorescence spectroscopy is commonly employed to study
conformational changes in purified proteins and proteins in
their native, cellular context (1,2). To faithfully and quanti-
tatively report atomic-scale motions, one must use small
fluorescent probes with short linkers that only minimally
perturb the structure of the protein under study (3). Further-
more, it is critical to ensure that the protein molecule of
interest is specifically labeled and that the overall fluores-
cence background is not too large.
Genetically encoded tags based on green fluorescent
protein (GFP) are highly specific (4). However, GFP is large
(~27 kDa), often as large as the protein of interest, which
makes it less useful for studying small movements (5).
Specific labeling has also been accomplished with the use
of genetically encoded His tags on proteins that bind
metal-chelating fluorophores (6). Although these tags are
much smaller than FP labels, both the tags and the fluoro-
phores used to label them are relatively long and flexible,
making them unfaithful reporters of the protein backbone
positions to which they are attached. Furthermore, they
are limited in terms of the location on the primary amino
acid sequence into which they can be inserted. Tetracysteine
motifs (cys-cys-xaa-xaa-cys-cys, where xaa is any amino
acid) that react with arsenated fluorophores also provide
specificity, but they require at least six residues in the proper
orientation and are likely to disrupt the local structure of the
protein into which they have been inserted (7).
The most faithful fluorescent reporters of protein back-
bone positions and conformational changes are small,
cysteine-reactive fluorophores (3,5). These dyes covalentlySubmitted November 10, 2010, and accepted for publication March 29,
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0006-3495/11/05/2513/9 $2.00attach to cysteine residues that are found natively in proteins
or introduced by site-directed mutagenesis. The smallest
dyes are similar in size to tryptophan and have very short
linkers, which enables them to attach to proteins without
causing any significant structural perturbation. However,
these fluorophores are not well suited for studies involving
mixtures of proteins or proteins in their native, cellular
context, where many other cysteine-containing proteins are
available to react with a given fluorophore, creating a high-
fluorescence background. Even purified proteins may have
multiple reactive cysteines that can obscure the fluorescence
signal originating from a labeled cysteine of interest.
Various strategies have been developed to circumvent this
problem. One approach identifies surface-accessible cyste-
ines on a protein of known structure, measures the kinetics
of cysteine modification at each residue, and uses the differ-
ence in modification rates to specifically label residues (8).
However, this method requires all accessible cysteines to
have substantially different reaction rates from the cysteine
of interest. Rather than relying on such good fortune, an ideal
labeling method would allow the experimenter to directly
manipulate the reaction kinetics of a desired cysteine relative
to background cysteines to provide specificity.One technique
uses proteins with multiple conformations, which may
contain cysteine residues that are accessible only in a subset
of states. These proteins can bemaintained in an inaccessible
state, which prevents the reaction of the desired cysteine
while background cysteines are blocked with a nonfluores-
cent modifier such as N-ethylmaleimide (NEM) (9,10).
After blocking is completed, the proteins can be shifted to
a state in which the cysteine is accessible and labeled with
fluorophore. This method requires a known residuewith state
dependence and allows little control over which part of
a given protein can be labeled. Another strategy to control
the reaction kinetics of specific cysteines involves theirdoi: 10.1016/j.bpj.2011.03.063
2514 Puljung and Zagottaincorporation into reversible disulfide bonds (11). This
method is highly specific when applied to purified proteins,
but in a native environmentmany cellular proteins have disul-
fide bonds or cysteines that can form disulfides under the
conditions used to oxidize the cysteines intended for
labeling. These cysteines would therefore still contribute to
a high-fluorescence background after reduction. Zinc finger
domains, which contain cysteines that can be protected by
metal ion binding, can be incorporated into proteins and
specifically labeled (11). However, this requires the insertion
of a structured domain of 18 amino acids, which will likely
perturb the protein intended for study. Kuiper and colleagues
(12) developed a labeling method whereby pairs of cysteines
in close proximity to one another are protected with
phenylarsine oxide while other cysteines are blocked. The
phenylarsine oxide is then reduced off with dithiothreitol,
and the cysteine pairs are subsequently available for modifi-
cation. However, this method is limited in that it can only
protect pairs of cysteines, both of which are then free to react
with fluorophore. Furthermore, it requires harsh reducing
agents to remove the protecting group, which may also
expose cysteines in native disulfide bonds to reaction with
fluorophores.
We have devised a novel (to our knowledge) method for
the reversible protection of cysteine residues using group
12 metal ion binding to minimal sites incorporated into ex-
isting secondary structural elements. We call this method
cysteine metal protection and labeling (CyMPL). CyMPL
requires only a slight perturbation of the protein of interest,
which makes it quite suitable for labeling a protein for
subsequent mapping of structures or conformational
changes. This technique can be applied to any region of
known secondary structure in virtually any protein, and
can be employed to specifically label a desired protein in
a mixture, specifically label a given cysteine in a protein
with multiple cysteines, or reduce the background fluores-
cence labeling in a cellular environment.MATERIALS AND METHODS
Molecular biology
The gene for the cysteineless HCN2I fragment (encoding residues 443–640
of the mouse HCN2 ion channel) was synthesized (Blue Heron Biotech-
nology, Bothell, WA) and cloned into the pMALc2T vector (New England
Biolabs, Ipswich, MA), which contains maltose binding protein (MBP)
separated from HCN2 by a thrombin cleavable linker (5,13). Mutant
MBP/HCN2 fusion proteins were prepared by polymerase chain reaction.
The GFP/Syntaxin1A/MBP K25C,K26C fusion (GFP-Syx-MBP) was
created and cloned into the GEMHE vector via standard polymerase chain
reaction techniques. mRNA was transcribed with the use of mMessage
mMachine (Ambion, Austin, TX) and the T7 polymerase.Peptides
Peptides were modeled after those published by Marqusee et al. (14) and
obtained from Sigma Genosys (Sigma-Aldrich, St. Louis, MO) and Amer-Biophysical Journal 100(10) 2513–2521ican Peptide (Sunnyvale, CA). The basic sequence was AAAAKAACAKA
AAAKA, with the N-terminus acetylated and the C-terminus amidated.
Histidines and cysteines were substituted at position 7 (iþ1), position 11
(iþ3), and position 12 (iþ4) as indicated in the text. The peptides arrived
lyophilized at >95% purity and were dissolved at a stock concentration
of 400 mM and stored at 80C.Protein purification
HCN2/MBP constructs were expressed in BL-21 (DE3) bacteria. Cultures
(2 L) were grown to OD600 between 0.6 and 0.9 at 37
C, induced with
1 mM isopropyl-1-thio-b-D-galactopyranoside, and shaken overnight at
18C. Bacteria were harvested by centrifugation at 4420  g for 15 min
at 4C and lysed into 150 mL of buffer containing 150 mM KCl, 10 mM
adenosine-30,50-cyclic monophosphate, 10% glycerol, and 30 mM HEPES,
pH 7.2, using an Emulsiflex-C5 (Avestin, Ottawa, Ontario, Canada). Before
the solution was homogenized, 1 mM phenylmethylsulfonyl fluoride,
2.5 mg/mL DNase, and one complete protease inhibitor tab (Roche, Indian-
apolis, IN) were added to the slurry. Cellular debris and insoluble proteins
were removed by centrifugation at 186,000  g for 45 min at 4C. The
fusion protein was purified on an amylose column (New England Biolabs)
and eluted into the above buffer plus 50 mM maltose. Some proteins were
cleaved with thrombin (100 U in 20 mL þ 5 mM CaCl2) for 4 h at room
temperature (Calbiochem, La Jolla, CA) and either used for subsequent
experiments or purified by ion exchange chromatography using a HiTrap
SP FF (GE Healthcare, Piscataway, NJ) column to purify HCN2 or HiTrap
Q FF (GE Healthcare) column for MBP, eluting on a KCl gradient from
10 mM to 1 M.Circular dichroism
For circular dichroism measurements, the peptide ACAAKAAAAKAA
WAKA, which could be readily quantified by A280 nm, was diluted to a final
concentration of 96 mM in 65 mM Na2SO4, 5 mM NaH2PO4, 5 mM
Na2HPO4, pH 7.2. Data were acquired with the use of an Aviv 62A DS
spectropolarimeter (Aviv Associates, Lakewood, NJ) at 25C in a 1-mm
path-length cuvette. Data were quantified according to the method of
Greenfield and Fasman (15). The spectra were similar for all the peptides
used in the experiments, but percent helicity was only quantified with the
tryptophan-containing peptide because it was the only peptide for which
the concentration was accurately determined by ultraviolet absorbance.Time course experiments
Cys-his peptides and glutathione were diluted to 20 mM in buffer containing
130 mM NaCl, 30 mM HEPES, pH 7.2. Bimane-C3 maleimide was diluted
to a final concentration of 2 mM in the same buffer. Then 125 mL of bimane
were mixed with 125 mL of peptide by pipetting the mixture up and down
for a final concentration of 10 mM peptide and 1 mM bimane. The increase
in bimane fluorescence was monitored with a Spex Fluorolog-3 spectroflu-
orometer (HORIBA Jobin Yvon, Edison, NJ) with excitation at 390 nm and
emission at 480 nm, each with a 5-nm slit width, sampling at 1 Hz. Data
were acquired with the use of FluorEssence software. The reaction of
cys-cys peptides was followed in the same way with a final concentration
of 1 mM peptide and 1 mM bimane. Proteins were diluted to 1– 10 mM
for time-course experiments. For the experiment shown in Fig. S2 of the
Supporting Material, modification time courses were acquired with the
above buffers plus 50% TFE or 4 M guanidinium chloride (GuHCl) as
indicated.Protein-labeling experiments
For selective labeling experiments, HCN2cys-free S563C,K565H (HCN-
cys,his) and MBP-HCN2cys-free K570C (MBP-HCN-cys) were combined
Specific Cysteine Labeling 2515at 1–2 mM each in buffer containing 130 mM NaCl and 30 mM HEPES,
pH 7.2. To selectively label MBP-HCN-cys, the mixture was reacted for
10 min using 1 mM fluorescein-5-maleimide (Flc) in the presence of
0–10 mM CdCl2. The products were run on a sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) gel and imaged on
a Fluorchem gel imaging system (Cell Biosciences, Santa Clara, CA)
with excitation set to 365 nm and standard ethidium bromide filters used
for emission. For selective labeling of HCN-cys,his, the protein mixture
was reacted for 10 min with 100 mM NEM in the presence of 0–10 mM
CdCl2. After 10 min, Cd
2þ was chelated with 25 mM EDTA and the
remaining protein was reacted for 10 min with 100 mM Flc. The products
were visualized as above. For experiments with HCN2cys-free K570C and
MBP K25C,K26C, the proteins were purified as a fusion, digested with
thrombin, and diluted to ~1 mM. Reactions were carried out in the same
fashion as for HCN-cys,his and MBP-HCN-cys.Oocyte-labeling experiments
Stage IV and V oocytes were removed from female Xenopus laevis frogs
under tricaine anesthesia as previously described (16). Defolliculated
oocytes were injected with 50 nL of water or mRNA encoding EGFP-Syn-
taxin1A-MBP K25C,K26C. For labeling, oocytes were shaken in 24-well
culture dishes for 30 min in OR2 (82.5 mM NaCl, 2.5 mM KCl, 1 mM
MgCl2, 5 mM HEPES, pH 7.6), OR2 plus 100 mM NEM, or OR2 with
100 mM NEM and 0.1–1 mM CdCl2. All solutions contained 100 mg/mL
bovine serum albumin to prevent the oocytes from sticking to the plastic
culture dishes. The oocytes were subsequently washed and incubated for
30 min in OR2 containing 5 mM EDTA and 10 mM AlexaFluor 546 malei-
mide. The oocytes were washed again and imaged with a Leica SL (Leica,
Bannockburn, IL) confocal microscope with laser excitation at 488 nm
(GFP) and 543 nm (Alexa).Data analysis
We analyzed the images using MetaMorph (Molecular Devices, Sunnyvale,
CA), and analyzed the image intensities and fluorescence data using Origin
8 (OriginLab, Northampton, MA). Time-course data were fit with single
exponential decays to determine the rate constants for reactions run under
pseudo-first-order conditions or by linear regression to the first ~10% of the
reaction. Concentration-response data were normalized to the reaction rate
at 0 Cd2þ and fit with the following expression for single-cysteine peptides
and proteins, or cysteine-histidine peptides and proteins:kapp
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2þ affinity of the cys-cys peptide; Kd2 refers
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It should be noted that the affinities measured for the cys-cys peptides (in
the low micromolar range) were on the same order of magnitude as the
1 mM peptide concentration used in the experiment. Ideally, a peptide
concentration lower than the Kd should be used to provide accurate
measurements of affinity. However, we did not use lower concentrations
of peptide, because they did not produce reliably measurable time courses.
The resulting concentration-response curves for Cd2þ binding to cys-cys
pairs were steep and the apparent Kd was difficult to determine. The actual
affinities are probably higher than those reported.Chemicals and reagents
Chemicals were obtained from Sigma (St. Louis, MO). All fluorophores
were purchased from Molecular Probes (Carlsbad, CA).RESULTS
Specific cysteine-labeling scheme
In addition to its distinctive chemical reactivity among
amino acids, cysteine readily binds the soft metal Cd2þ
(17). Cd2þ binding can slow the rate of reaction of a cysteine
with thiol-modifying reagents. We hypothesized that if we
could selectively enrich Cd2þ binding to a cysteine of
interest while leaving the background cysteines unbound,
we could then use reversible Cd2þ binding as a tool to
protect specific cysteines from modification while blocking
the background cysteines. We could then specifically label
the desired cysteine after removing the Cd2þ. With this in
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FIGURE 1 Design of the cysteine protection method. (A) Schematic
diagram depicting the specific cysteine protection method, CyMPL. The
Cd2þ binding affinity of a desired cysteine is increased by placing an addi-
tional metal-binding amino acid nearby. Cd2þ is used to protect the desired
cysteine while background cysteines are reacted with a nonfluorescent
modifying reagent. Upon removal of Cd2þ, the specific cysteine is available
to react with fluorophore. (B) Reaction scheme for cysteine reacting with
bimane C3-maleimide and competitive binding by Cd
2þ. (C) Time course
of fluorescence increase upon reaction of the Cys Only peptide with bimane
C3-maleimide at different [CdCl2]. (D) Concentration-response curve
showing the rate (normalized to 0 Cd2þ) of the reaction of the Cys Only
peptide with bimane C3-maleimide as a function of [CdCl2]total. Data
were fit with a single-site binding curve (see Materials and Methods). (E)
Box plot showing the apparent Kd and DG for Cd
2þ binding to Cys Only
peptide, GSH, and the cysteine-free C-terminal region of the HCN2 ion
channel with a single cysteine inserted at position 563 (HCN2 S563C) or
position 570 (HCN2 K570C).
TABLE 1 Metal affinities and binding energies
Kd (mM) DG (kcal mol
1) n
Cys Only 1585 8 5.105 0.032 5
Glutathione 1125 4 5.305 0.022 5
HCN2 S563C 1575 42 5.175 0.143 5
HCN2 K570C 1585 28 5.145 0.110 5
Cys/His iþ1 27.85 3.2 6.135 0.066 5
Cys/His iþ3 13.55 0.8 6.545 0.038 5
Cys/His iþ4 16.25 1.8 6.445 0.065 5
Cys/His iþ3,4 4.695 0.58 7.175 0.087 5
Cys/Cys iþ1 1.795 0.67 8.035 0.361 5
Cys/Cys iþ3 1.775 0.52 7.895 0.219 6
Cys/Cys iþ4 0.945 0.24 8.185 0.174 5
HCN2 S563C/K565H 6.045 2.32 7.275 0.267 6
MBP E22C,K25C 3.685 1.29 7.475 0.205 6
MBP K25C,K26C 3.065 1.08 7.535 0.195 5
GuHCl Cys Only 59.05 3.5 5.685 0.034 5
Glutathione 2155 11 4.925 0.031 5
Cys/His iþ4 30.35 3.2 6.085 0.067 6
Cys/His iþ3,4 25.55 6.1 6.235 0.135 5
TFE Cys Only 1025 9 5.365 0.055 5
Cys/His iþ4 24.55 6.1 6.255 0.139 5
Cys/His iþ3,4 6.725 1.49 7.005 0.111 6
Zn2þ Cys Only 1,0905 290 4.075 0.171 5
Cys/His iþ4 28.15 3.3 6.125 0.071 5
Values for Kd andDG of Cd
2þ binding are given for peptides and proteins in
aqueous buffer, 4 M GuHCl (GuHC1), and 50% TFE (Zn2þ). Values for Kd
and DG of Zn2þ binding are also indicated (top row). All numbers are
expressed as mean5 SE; n refers to the number of experiments.
2516 Puljung and Zagottaa given cysteine is increased by the addition of one or two
metal binding amino acids in the vicinity that will act
with cysteine as a bidentate (or tridentate) ligand to coordi-
nate Cd2þwith relatively high affinity. In Fig. 1A, a histidine
residue is introduced into a protein near a desired cysteine.
Upon addition of a low concentration of Cd2þ (i), these resi-
dues will coordinate the metal ion but individual back-
ground cysteines will not. Unbound cysteines can then
react with a thiol-modifying reagent (e.g., NEM (ii)) while
at the same time the metal-bound cysteine will be protected.
After metal chelation (e.g., with EDTA (iii)), the cysteine of
interest is again available to react with the applied fluoro-
phore (iv) while the background cysteines are covalently
blocked.Design of metal-binding sites
To optimize the metal-binding sites for cysteine protection,
we created a series of peptides based on the design of
Marqusee et al. (14), which are substantially helical in
aqueous solution. Into these peptides we introduced
a cysteine alone or in combination with additional chelating
residues. We measured the rate of peptide reaction with the
thiol-modifying reagent bimane C3-maleimide (bimane),
which showed a large fluorescence increase upon reaction
(Fig. 1 B). Under pseudo-first-order conditions, the reaction
time course can be fit with a single exponential decay to
determine an apparent rate constant for the reaction, kapp.Biophysical Journal 100(10) 2513–2521Cd2þ slowed the reaction rate of a single cysteine with
bimane in a concentration-dependent manner (Fig. 1, B
and C). By plotting the normalized (to zero added Cd2þ)
rate constants of the reaction as a function of the total
[Cd2þ] and fitting with the appropriate expression, we were
able to determine the Cd2þ affinity (Fig. 1 D; see Materials
and Methods). Fig. 1 E shows the apparent Cd2þ affinity
and binding free energy for single cysteines in a helical
peptide (Cys Only peptide), in glutathione (GSH), and in
two purified proteins with single cysteines (the cysteine-
free cytoplasmic domain of the mouse HCN2 ion channel
with single cysteines introduced at positions 563 or 570)
(5). In all cases, the Cd2þ protection of cysteine occurred
over nearly identical concentration ranges, regardless of the
protein or peptide context, with affinities similar to those
previously reported for Cd2þ binding to GSH (18). It should
be noted that a significant amount of Cd2þ is expected to bind
to Cl in the buffer and potentially to the quartz cuvette used
in these experiments (18,19). Therefore, all affinities are
reported as the apparent Kd, and the actual affinities may be
higher.
Specific Cysteine Labeling 2517We next tested the Cd2þ binding affinity of several helical
peptides containing a cysteine residue at the same location,
but with histidine residues inserted right next to the cysteine
(Cys/His iþ1), one helical turn away (Cys/His iþ3 and Cys/
His iþ4), or with two histidines one turn away from the
cysteine (Cys/His2 iþ3,4; Fig. 2 A). As predicted, the histi-
dines were able to coordinate metal with the cysteine and
slow the rate of reaction with bimane at significantly lower
Cd2þ concentrations compared with cysteine alone (Fig. 2,
B–D, and Table 1). Insertion of a histidine right next to
the cysteine increased the binding affinity to 27.8 mM
(stabilization of binding by 1.03 kcal/mol). Placing the
histidine residue one helical turn away at iþ3 (13.5 mM,
stabilized by 1.44 kcal/mol) or iþ4 (16.2 mM, stabilized
by 1.34 kcal/mol) caused an even greater stabilization
of binding. Inserting two histidines at iþ3 and iþ4 provided
the greatest increase in affinity (4.69 mM, stabilized by
2.07 kcal/mol). Zn2þ also binds cysteine, although
(being a harder metal) not as well as Cd2þ (Fig. S1 and
Table 1). The Cys Only peptide bound Zn2þ with 1.09 mM
affinity. Inserting a histidine at position iþ4 relative to the
cysteine increased the affinity to 28.1 mM (stabilization of
2.05 kcal/mol).
We also examined the Cd2þ affinity for peptides with
pairs of cysteines (Fig. 2, C and D). Because each cys-cys
peptide had two reactive cysteines and two potential metalA
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cysteine, cys-his binding sites, and cys-cys binding sites.affinities (i.e., the affinity of two cysteines for metal and
the affinity after one cysteine reacted), the actual reaction
scheme is more complicated than the one shown in
Fig. 1 B. To simplify our analysis, we examined only the
initial portion of the reaction where the fluorescence
increase was linear with respect to time. We assumed that
no appreciable amount of reacted peptide had accumulated
during this time, and therefore the measured rates and
inferred Cd2þ affinities were solely the result of the reaction
and binding of the unreacted cys-cys peptide. The addition
of a second cysteine at position iþ3 allowed Cd2þ to reduce
the rate of reaction with bimane at much lower concentra-
tions than for cysteine alone or any of the cys-his pairs tested
(Fig. 2 C). The increased affinity compared with cys-his
peptides may reflect the compatible binding properties of
cysteine with the soft metal Cd2þ. Cd2þ affinities of the
cys-cys peptides (iþ1, iþ3, iþ4) were increased by a factor
of 88–168 (2.8–3.1 kcal/mol) over the Cys Only peptide
(Fig. 2 D). Similar results were obtained in two mutants
of the natively cysteine-free Escherichia coli MBP with
cysteines inserted right next to each other (MBP
K25C,K26C) or one turn away (MBP E22C,K25C; Fig. 2 A)
in a known helical region (Fig. 2 D) (20).
Circular dichroism measurements for the above peptides
showed characteristic minima at 208 nm and 220 nm,
indicative of an a-helical structure (Fig. S2). However, theC
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d Cys/Cys iþ3 with bimane C3-maleimide as a function of [CdCl2]total. Data
ent Kd and DG for Cd
2þ binding to peptides or proteins containing a single
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aqueous buffers at 25C. In the presence of 50% 2,2,2-tri-
fluoroethanol (TFE), a solvent that promotes helix forma-
tion, the calculated helicity was 70% (15). To determine
whether the introduced metal binding sites were helical,
we used reagents to drive the folding equilibrium for our
peptides toward a-helix (50% TFE) or random coil (4 M
GuHCl). The increased Cd2þ binding stability of our
peptides in aqueous buffer compared with cysteine alone
more closely resembled the stabilization in TFE than stabi-
lization in the presence of GuHCl (Fig. S2 B). We conclude
that the metal-binding sites were substantially helical. In
addition to these experiments, the observation that the
cys-cys MBP mutants, which are known to be in a helical
portion of the protein, bind Cd2þ with similar affinity to
the cys-cys peptides provides further evidence that the
metal-binding sites in the model peptides adopt a helical
structure (Fig. 2 D).
We next investigated whether a minimal metal-binding
site could be incorporated into a b-strand. As a model
system, we used the b roll of the cysteine-free C-terminal
domain of the mouse HCN2 ion channel (5,13). First, we
introduced a cysteine at position 563 in the b roll (Fig. 3 A).
The affinity was measured and was nearly identical to
that measured for the Cys Only peptide (Fig. 3 B, Table
1). Introduction of a histidine residue at position 565
(residue iþ2; Fig. 3 A) provided a 26-fold increase in
Cd2þ binding (2.1 kcal/mol stabilization; Fig. 3 B and Table
1). We conclude that it is possible to incorporate small
metal-binding sites into any regular secondary structure,
a-helix, or b-strand.HCN2cys-freeS563C HCN2cys-freeS563C,K565H
A
B
ΔG
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K
d (
M
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FIGURE 3 Cd2þ binding to a b-strand metal-binding site. (A) Cartoons
depicting b-strand Cd2þ-binding sites containing a single cysteine
(HCN2cys-free S563C) and a cys-his pair (HCN2cys-free S563C,K565H).
(B) Box plot showing the apparent Kd and DG for Cd
2þ binding to Cys-
only peptide, and the constructs depicted in A.
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mixture
A potential application of this technique would be to selec-
tively label one protein in a mixture of other soluble
proteins. To test this, we prepared an equimolar mixture
of two proteins, a fusion of MBP and HCN2 with a single
cysteine in the b roll (MBP-HCN2cys-free K570C, referred
to as MBP-HCN-cys) and the HCN2 C-terminal region
with a cys-his binding site in the b roll (HCN2cys-free
S563C,K565H, referred to as HCN-cys,his; Fig. 4 A). The
Cd2þ affinities of the individual proteins were 158 mM for
HCN2cys-free K570C (Fig. 1 E) and 6 mM for HCN2cys-free
S563C,K565H (Fig. 3 B).
The first test was to label the MBP-HCN fusion and
protect HCN-cys,his from labeling (Fig. 4 B). Because the
Cd2þ affinity was ~26-fold higher for HCN-cys,his than
for MBP-HCN-cys, we expected to achieve specific labeling
ofMBP-HCN-cys by reacting themixturewith a fluorophore
in the presence of low concentrations of Cd2þ that would
protect HCN-cys,his but not MBP-HCN-cys. Flc was
applied to the mixture in the presence of increasing concen-
trations of Cd2þ. The reaction products were separated on an
SDS-PAGE gel and the fluorescent bands were imaged to
assess labeling intensity. As the [Cd2þ] was increased above
1 mM, HCN-cys,his was protected from reaction with Flc as
predicted, consistent with the measured affinity (Fig. 4 C).
In contrast to this, MBP-HCN-cys was maximally labeled
at concentrations below 1 mM. At 100 mM Cd2þ, MBP-
HCN-cys labeled 18 times more brightly than HCN-cys,his,
even though the two proteins labeled with similar intensities
in the absence of Cd2þ.
We also performed a converse experiment (Fig. 4 D) in
which we reacted the same mixture of proteins with NEM
in increasing amounts of Cd2þ. At low [Cd2þ], we expected
HCN-cys,his to be protected from NEM block and the
cysteine in MBP-HCN-cys to be modified. After metal
chelation with EDTA, the remaining unreacted cysteines
were labeled with Flc. As predicted, HCN-cys,his was
protected from NEM modification at lower [Cd2þ], and
therefore was available to react with Flc after Cd2þ was
removed (Fig. 4 E). HCN-cys,his labeled at Cd2þ concentra-
tions above 1 mM, whereas MBP-HCN-cys was blocked
below 1 mM Cd2þ. At 100 mM Cd2þ, HCN-cys,his labeled
40 times more brightly than MBP-HCN-cys. HCN-cys,his
labeling at 100 mM Cd2þ was 70% as bright as in the
absence of Cd2þ or NEM, indicating that although unde-
sired background reaction with fluorophore was virtually
eliminated, the overall labeling intensity was not appre-
ciably compromised (Fig. 4 E, far-right lane).
We repeated the above experiments using two different
proteins: HCN2cys-free K570C, with a single cysteine in
the b roll, and MBP K25C,K26C, with two adjacent cyste-
ines in a surface-accessible helix (Fig. S3 A). The Cd2þ
affinities of the individual proteins were 158 mM for
50
37
25
0 NEM
0 Cd2+
50
37
25
MBP-HCN-cys
HCN-cys,his
E
C
NEM + Cd2+ Flc + EDTA
Flc + Cd2+
A B
D
MBP-HCN-cys
HCN-cys,his
(65.80 kDa)
HC
(23.41 kDa)
C
Cd2+
C
Cd2+ MBP-HCN-cys
HCN-cys,his
10-80
[CdCl2] (M)
10-7 10-6 10-5 10-4 10-3 10-2
10-70
[CdCl2] (M)
10-6 10-5 10-4 10-3 10-2
HC HC
C C
C C
HC HC HC
FIGURE 4 Application of protection of a cys-his
motif to label individual components in a mixture
of soluble proteins. (A) Cartoon showing HCN2
with a cys-his pair in the b roll (HCN2cys-free
S563C,K565H; HCN-cys,his) and a fusion of
MBP and HCN2 with a single cysteine (MBP-
HCN2cys-free K570C; MBP-HCN-cys). (B) Sche-
matic diagram representing an experiment in a
mixture of proteins in solution in which MBP-
HCN-cys is labeled with Flc while HCN-cys,his
is protected from reaction with Flc by binding
Cd2þ. (C) SDS-PAGE showing Flc labeling of
MBP-HCN-cys and HCN-cys,his at increasing
[CdCl2]. A Coomassie stain of the same gel is
shown below. (D) Schematic diagram representing
an experiment in which HCN-cys,his is selectively
labeled with Flc by first protecting it with Cd2þ
while MBP-HCN-cys is blocked with NEM, and
then removing Cd2þ and labeling the deprotected
HCN-cys,his with Flc. (E) SDS-PAGE showing
Flc labeling of MBP-HCN-cys and HCN-cys,his
after reaction of the proteins with NEM in
increasing [CdCl2]. The final lane shows labeling
of both proteins in the absence of Cd2þ or NEM.
A Coomassie stain of the same gel is shown below.
Specific Cysteine Labeling 2519HCN2 K570C (Fig. 1 E) and 3 mM for MBP K25C,K26C
(Fig. 2 D). The proteins were copurified as a fusion on an
amylose column and cleaved with thrombin to yield a 1:1
mixture. The results obtained were very similar to the
mixture of proteins shown in Fig. 4 (Fig. S3).Reducing background labeling in a cellular
environment
To demonstrate the utility of our method for increasing the
signal/background ratio in a cellular environment,we createdCC
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NEM block (gray), and after 100 mM NEM block in the presence of 100 mMa fusion protein with MBP K25C,K26C attached to the
C-terminus of the single-pass membrane protein Syntaxin1A
so that MBP would be located on the extracellular side of
the membrane. The N-terminus of Syntaxin1Awas fused to
GFP so that relative levels of protein expression could be
monitored (GFP-Syx-MBP; Fig. 5 A). Intact Xenopus laevis
oocytes injected with RNA encoding GFP-Syx-MBP and
water-injected oocytes were labeled extracellularly with
10 mM AlexaFluor 546 C5 maleimide (Alexa). Before the
Alexa labeling was performed, some oocytes were blocked
with NEM in the presence or absence of Cd2þ. The results Block
M Block
M Block + 100 μM CdCl2
M Block + 1 mM CdCl2
Control
NEM Block
NEM Block
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FIGURE 5 Application of the cysteine protec-
tion method to reduce the fluorescence back-
ground when labeling a protein in a cellular
environment. (A) Cartoon depicting the fusion
protein expressed in Xenopus laevis oocytes for
extracellular labeling experiments. The protein
is based on the single-pass membrane protein
Syntaxin1A with GFP fused to the N-terminus
(intracellular) and MBP K25C,K26C fused to the
C-terminus (extracellular). (B) Confocal images
of Xenopus laevis oocytes injected with mRNA
encoding GFP-Syx-MBP or water (control).
Oocytes were labeled with Alexa Fluor 546 C5
maleimide after incubation in buffer, buffer con-
taining 100 mM NEM, or buffer containing
100 mM NEM þ 1 mM CdCl2. Scale bar ¼
500 mm. (C) Plot showing the intensity of Alexa-
Fluor 546 C5 maleimide labeling versus GFP fluo-
rescence for oocytes injected with RNA encoding
GFP-Syx-MBP with no block (cyan circles), after
100 mM NEM block (gray triangles), and after
100 mM NEM block in the presence of 100 mM
(magenta squares) or 1 mM (green diamonds)
intensity of water-injected oocytes with no block (cyan), after 100 mM
(magenta) or 1 mM (green) CdCl2.
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directly analogous to the scheme presented in Fig. 1 A.
Oocytes expressing GFP-Syntaxin-MBP labeled brightly
with Alexa and also demonstrated bright GFP fluorescence
(Fig. 5 B). Background Alexa labeling is illustrated by the
degree of labeling in control (water-injected) oocytes
(Fig. 5B). It is evident from a comparison of these two condi-
tions that a significant portion of the fluorescence intensity
in the GFP-Syx-MPB-expressing oocyte arose from non-
specific background labeling. When GFP-Syntaxin-MBP
oocytes were preblocked with NEM in the absence of
Cd2þ, there was very little labeling from subsequent expo-
sure to Alexa (Fig. 5 B). At low [Cd2þ], the cysteines on
GFP-Syx-MBPwere expected to bind Cd2þ and be protected
fromNEMblock, and therefore free to react with Alexa upon
Cd2þ removal. The background cysteines in the oocyte
membrane were not expected to bind Cd2þ and should
therefore have been blocked by NEM. Consistent with this
prediction, GFP-Syx-MBP expressing oocytes that were
blockedwithNEM in the presence of 1mMCd2þ still labeled
with Alexa (Fig. 5 B). In similarity to the GFP-Syx-MBP-
expressing oocytes, labeling was blocked by NEM pretreat-
ment in control oocytes (Fig. 5 B). The presence of 1 mM
Cd2þ protected very little of this background labeling from
block by NEM (Fig. 5 B).
In Fig. 5 C, the amount of oocyte membrane labeling by
Alexa is plotted as a function of GFP fluorescence (i.e.,
GFP-Syx-MBP). With no NEM block, there is a clear linear
relationship (R ¼ 0.8 from linear regression to the data)
between the intensity of Alexa labeling and GFP fluores-
cence (Fig. 5 C). The Y-intercept at zero GFP fluorescence
indicates the background Alexa labeling when there was no
GFP-Syx-MBP expression. This level is comparable to the
amount of labeling by 10 mM Alexa in water-injected
oocytes (Fig. 5 D). When the oocytes were pretreated with
NEM (100 mM) before Alexa labeling, most of the labeling
was blocked and Alexa fluorescence no longer correlated
(R ¼ 0.2) with GFP fluorescence (Fig. 5 C). The small
amount of labeling that remained is likely due to Alexa
accumulating in the membranes surrounding the oocyte,
and is comparable to the amount of labeling in control
oocytes that were preblocked with NEM (Fig. 5 D).
When 100 mM and 1 mM Cd2þ were present during NEM
block, the increase in Alexa labeling once again correlated
with the amount of GFP fluorescence (R ¼ 0.8 and R ¼
0.9, respectively; Fig. 5 C). At 1 mM Cd2þ, the slope was
indistinguishable from that of the unblocked oocytes, but
the intercept was reduced to 45% of its original value, indi-
cating a reduction in background. When 100 mM Cd2þ was
present during NEM application, the background (Y-inter-
cept) was completely blocked to the same level observed
with no Cd2þ present. The slope was marginally reduced,
by a factor of 1.78, indicating that there was also a small
reduction in the labeling of GFP-Syx-MBP. Blocking back-
ground in the presence of 100 mM Cd2þ increased theBiophysical Journal 100(10) 2513–2521signal/background ratio more than threefold over oocytes
with no NEM block. In contrast to this, control oocytes
demonstrated very little additional fluorescence when
Cd2þ was present during NEM block (Fig. 5 D).DISCUSSION
We have presented a new (to our knowledge) method that
increases the specificity of site-directed fluorescent labeling
of a desired protein. This method, which we call CyMPL,
involves the introduction of cysteine-containing minimal
metal-binding sites into regions of known secondary struc-
ture. These sites coordinate group 12 metal ions such as
Cd2þ and Zn2þ with high affinity to protect a cysteine
from reaction with thiol-modifying compounds. The fluo-
rescence background can then be reduced through the cova-
lent blockade of undesired cysteines. We demonstrated the
ability of this method to label a single component in a
mixture of proteins or to increase the signal/background
ratio for the labeling of a membrane protein in Xenopus
oocytes, where large background labeling results from the
expression of unknown proteins. The specific applications
presented here show the great promise of this method for
specifically labeling individual cysteines or cysteine pairs.
In every application of our method, the results were consis-
tent with the binding affinities measured for the individual
protein components. Therefore, these constants, which
were remarkably similar for cysteines in a variety of protein
backgrounds, can be used as guidelines to design a specific
labeling protocol for virtually any protein of known
secondary structure.
This technique has advantages over previously established
methods for site-directed fluorescence labeling. Although
many of these methods provide specificity, they involve the
insertion of entire structured protein motifs ranging from
six (e.g., polyhistidine and tetracysteine motifs used for
FlAsH) or 18 amino acids (zinc finger domains) to 238
amino acids (GFP) or more. Our method requires as few as
two point mutations (fewer if one uses native amino acids)
inserted into existing secondary structural elements (i.e.,
a-helix or b-strand). When coupled with small, cysteine-
reactivefluorophoreswith short linkers, thismethod provides
specific labeling of a protein with minimal structural
perturbation.
The efficacy of our method relies on the selective increase
in metal-binding affinity of a desired cysteine. This is
accomplished by placing histidine or cysteine residues on
the same side of an a-helix or b-strand close to the cysteine
intended for labeling. A large increase in Cd2þ affinity was
demonstrated with the use of cys-his pairs in a-helical struc-
tures; however, an even greater increase in affinity resulted
from the use of cys-cys pairs (although cys-his pairs with
Zn2þ displayed great promise). When cys-cys pairs are
used, the protein of interest will have two reactive cysteines
after metal chelation. These cysteines can be reacted either
Specific Cysteine Labeling 2521with two molecules of fluorophore or with a bifunctional
fluorophore such as dibromobimane (21). Indeed, dibromo-
bimane reacts readily with cys-cys pairs in all of our dicys-
teine peptides to produce a single product labeled with only
one bimane molecule (Fig. S4). Although our chosen exam-
ples all used maleimide-linked fluorophores and nonfluores-
cent blockers, the method should readily extend to the use of
methanethiosulfonate reagents, iodoacetamides, and other
linkages. The use of methanethiosulfonate reagents as
nonfluorescent blockers in a labeling experiment would
allow for the removal of the blocker with a reducing agent
after labeling (if a nonreducible fluorophore is used to
label). This would reduce any effect the blocking agent
might have on the protein of interest or other cellular
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